boolean
Dr. John Lekkas

Reviewed By: Dr. John Lekkas

GMC Registration: 7448560

Last reviewed on: 31/08/2026

Shipping Across the UK

Icon UK Mainland Weekday delivery

Icon Channel Islands (Two-day delivery service)

Icon Northern Ireland (one to two-day delivery service)

Icon Shipped Monday - Friday

Foundayo (Orforglipron)

Foundayo is a prescription-only weight management medicine developed by Eli Lilly, the pharmaceutical company behind Mounjaro. It contains orforglipron and is taken once daily to support weight loss and weight maintenance in eligible adults.

The medicine should be used alongside a reduced-calorie diet and increased physical activity to support ongoing weight management.

Foundayo is now available. Complete an online consultation to find out whether treatment is suitable for you.

Prices include prescription

0.8mg (4 x doses of 0.8mg) The starting dose of Foundayo is 0.8mg once daily for the first 30 days, allowing your body time to adjust before a dose increase is considered. £
2.5mg (4 x doses of 2.5mg) The 2.5mg dose is the next stage of treatment, helping to support appetite control and continued weight management. £
5.5mg (4 x doses of 5.5mg) The 5.5mg dose builds on the earlier stages of treatment to support ongoing appetite regulation and weight loss. £
9mg (4 x doses of 9mg) The 9mg dose provides a further increase in treatment strength to support continued weight management. £
14.5mg (4 x doses of 14.5mg) The 14.5mg dose is a higher treatment strength that may be prescribed as you progress through the Foundayo dosing schedule. £
17.2mg (4 x doses of 17.2mg) The 17.2mg dose is the highest Foundayo dose and may be used for ongoing weight management when clinically appropriate. £
Dosage

New to Foundayo? You’ll start on 0.8mg

0.8mg
2.5mg
5.5mg
9mg
14.5mg
17.2mg

The starting dose of Foundayo is 0.8mg once daily for the first 30 days, allowing your body time to adjust before a dose increase is considered.

Dr. John Lekkas

Reviewed By: Dr. John Lekkas

GMC Registration: 7448560

Last reviewed on: 27/08/2026

Shipping Across the UK

Icon UK Mainland Weekday delivery

Icon Channel Islands (Two-day delivery service)

Icon Northern Ireland (one to two-day delivery service)

Icon Shipped Monday - Friday

Foundayo dosages

Foundayo is available in six dose strengths. Treatment begins with a low daily dose, which is gradually increased to help your body adjust to the medicine and reduce the likelihood of side effects. Dose increases are usually considered after at least 30 days on the current dose.

Treatment stage Daily Foundayo dose
Starting dose 0.8 mg
Month 2 2.5 mg
Month 3 5.5 mg
Month 4 9 mg
Month 5 14.5 mg
Maximum dose 17.2 mg

Our clinician will regularly assess your response to Foundayo (orforglipron) and any side effects you experience to determine the most appropriate dose for your treatment. Any dose increase should be made only on our clinician’s advice and in line with the recommended Foundayo dosing schedule.

How our weight loss service works

Fill Out Free Consultation

Fill out the Online Form

Fill out our online consultation form with valid and accurate patient information and medical conditions.

Select Treatment

Select Treatment

Select the weight loss treatment you are prescribed. We will suggest the options based on your eligibility.

Track & Receive

Track & Receive

Your treatment will be dispensed and delivered to your doorstep by a tracked courier service.

What is Foundayo?

Foundayo pill contains orforglipron, a non-peptide, small-molecule GLP-1 receptor agonist. Unlike peptide-based GLP-1 medicines, orforglipron has a small-molecule structure that allows it to be formulated as an oral tablet without specific fasting requirements.

The Foundayo tablet is swallowed whole and can be taken at any time of day, with or without food. Its administration requirements allow the daily dose to fit around an individual's usual routine.

What is Foundayo?
Who is eligible for Foundayo?

Who is eligible for Foundayo?

Foundayo may be suitable for adults who meet one of the following body mass index (BMI) criteria:

  • BMI of 30 kg/m² or above, or
  • BMI of 27 kg/m² or above with at least one weight-related health condition, such as prediabetes, type 2 diabetes, high blood pressure, abnormal blood fats, obstructive sleep apnoea or certain cardiovascular conditions.

Foundayo is used alongside a reduced-calorie diet and increased physical activity as part of a weight management plan. It is intended for adults and should not be used in children or adolescents under 18 years of age, as it has not been studied in this age group.

How does Foundayo work?

Foundayo’s active ingredient, orforglipron, works by binding to and activating GLP-1 receptors, mimicking the effects of the naturally occurring GLP-1 hormone. These receptors are involved in regulating appetite, digestion and blood glucose levels.

For weight management, Foundayo tablet works in several ways:

  • Reduces appetite: Helps reduce hunger and food cravings, which may support a lower food intake.
  • Increases fullness: Helps you feel fuller for longer after eating.
  • Slows digestion: Delays the rate at which food leaves the stomach, which can contribute to longer-lasting feelings of fullness.
  • Regulates blood glucose: Helps support blood glucose control through its GLP-1 activity.

Together, these effects can support weight loss and weight maintenance when Foundayo is used alongside a reduced-calorie diet and increased physical activity.

How does Foundayo work?
Effective Foundayo?

How effective is the Foundayo pill?

The effectiveness of the Foundayo pill was studied in the Phase 3 ATTAIN-1 trial, which included 3,127 adults with obesity or overweight and at least one weight-related health condition, without diabetes. Participants received once-daily orforglipron or placebo alongside a healthy diet and physical activity for 72 weeks.

Using the efficacy estimand, participants receiving the highest 36 mg study dose achieved an average weight loss of 12.4% after 72 weeks. At this study dose:

  • 77.1% lost at least 5% of their starting body weight
  • 59.6% lost at least 10%
  • 39.6% lost at least 15%
  • 20.1% lost at least 20%

The study also reported improvements in cardiometabolic measures, including waist circumference, systolic blood pressure, triglycerides and non-HDL cholesterol.

Please note: These figures are based on the efficacy estimand from the ATTAIN-1 clinical trial. Individual weight loss can vary, and trial results do not guarantee how much weight a person will lose during treatment.

How to take Foundayo

Foundayo is taken as one tablet once daily and can be taken at any time of day, with or without food. Swallow the tablet whole, with water if needed, and do not break, crush or chew it. Do not take more than one Foundayo tablet per day.

There are no specific fasting or water restrictions when taking Foundayo, so the dose does not need to be scheduled around meals. Taking it at a consistent time each day may also help you remember your daily dose.

Always follow the dosing instructions provided by our clinician and the patient information leaflet.

What if I miss a dose of Foundayo?

If you forget to take Foundayo, take the missed dose as soon as you remember. Do not take more than one dose in a day or take a double dose to make up for a forgotten tablet.

What if I take too much Foundayo?

If you take more Foundayo tablets than prescribed, speak to our doctor immediately. Taking too much can cause nausea or vomiting.

What happens if I stop taking Foundayo?

Do not stop taking Foundayo without speaking to our doctor first. After stopping treatment, its effects on appetite may reduce over time, which could lead to increased hunger and make weight regain more likely.

If you have type 2 diabetes, stopping the Foundayo pill may also cause your blood glucose levels to increase. Speak to our doctor before stopping treatment so they can advise you on the appropriate next steps based on your individual circumstances.

How long do you need to take Foundayo for?

Foundayo tablet is intended for long-term weight management when treatment remains suitable and effective. In the ATTAIN-1 clinical trial, participants received orforglipron for 72 weeks. Treatment duration varies between individuals, and our clinician will advise you based on your response, progress and overall health.


Foundayo side effects

Like all medicines, Foundayo tablets can cause side effects, although not everyone will experience them. Nausea, diarrhoea and vomiting are most common when starting orforglipron and tend to decrease over time in most people.

Very common side effects (may affect more than 1 in 10 people) include:

  • Nausea
  • Constipation
  • Diarrhoea
  • Vomiting
  • Indigestion (dyspepsia)
  • Abdominal pain
  • Low blood sugar (hypoglycaemia) when Foundayo tablet is used with insulin, with or without certain other diabetes medicines

Common side effects (may affect up to 1 in 10 people) include:

  • Low blood sugar when used with a sulfonylurea alone or alongside other type 2 diabetes medicines
  • Dizziness
  • Headache
  • Fast pulse
  • Low blood pressure
  • Abdominal bloating
  • Burping
  • Reflux or heartburn
  • Gas (flatulence)
  • Gallstones
  • Hair loss
  • Tiredness
  • Increased levels of pancreatic enzymes, such as lipase and amylase, in the blood

Uncommon side effects (may affect up to 1 in 100 people) include:

  • Low blood sugar when orforglipron is used without insulin or a sulfonylurea
  • An unusual sense of taste
  • An unpleasant or abnormal sensation when touched
  • Acute pancreatitis, which can cause severe and persistent pain in the stomach and back and requires immediate medical attention.

Some serious orforglipron side effects have also been reported where the frequency is not known. These include sudden changes in vision, bowel obstruction, severe constipation, serious allergic reactions and kidney problems. Seek medical advice promptly if you develop severe or concerning symptoms.

See the Foundayo patient information leaflet for the complete list of side effects and safety information.

How long do Foundayo side effects last?

Common Foundayo side effects may last from a few days to a few weeks, although this can vary between individuals. Nausea, diarrhoea and vomiting are more common when first starting treatment and may also occur around dose increases. These effects often improve as your body adjusts to the medicine.

If side effects persist, become worse or are difficult to manage, speak to our clinician for advice.

What to do if you get Foundayo side effects

Some common digestive side effects may be managed with simple changes to your diet and daily routine:

  • Nausea: Try smaller, more frequent meals and avoid foods that make your symptoms worse.
  • Vomiting: Take small, regular sips of water to help prevent dehydration and seek medical advice if you cannot keep fluids down.
  • Diarrhoea: Drink plenty of fluids to replace the water your body loses and help prevent dehydration.
  • Constipation: Keep well hydrated, gradually increase dietary fibre where appropriate and remain physically active.
  • Indigestion: Eating smaller meals and avoiding foods that trigger your symptoms may help.

Speak to a healthcare professional before taking medicines to manage orforglipron side effects if you are unsure whether they are suitable alongside Foundayo.

When to seek medical help

Some Foundayo side effects require prompt medical attention. Contact a healthcare professional immediately if you develop symptoms of a serious reaction or complication, including:

  • Acute pancreatitis: Severe, persistent stomach pain that may spread to your back.
  • Sudden changes in vision: Sudden loss of vision or a noticeable change in your eyesight.
  • Bowel obstruction: Severe stomach pain, abdominal swelling or bloating, vomiting, or being unable to pass stool or wind.
  • Severe constipation: Difficulty opening your bowels, particularly with significant stomach pain or bloating.
  • Serious allergic reaction: Swelling of the face, lips, tongue or throat, difficulty breathing or swallowing, dizziness or weakness.
  • Kidney problems or severe dehydration: Persistent vomiting or diarrhoea may cause significant fluid loss and affect kidney function.

Tell your doctor, anaesthetist or other healthcare professional that you are taking Foundayo before any surgery or procedure requiring anaesthesia or deep sedation.


Foundayo warnings

Foundayo may not be suitable for everyone. Before starting treatment, tell our clinician about any medical conditions you have so they can determine whether the medicine is appropriate for you.

Do not take Foundayo tablets if you are allergic to orforglipron or any of the other ingredients in the medicine.

Before taking Foundayo, tell our clinician if you:

  • Have or have previously had pancreatitis
  • Take insulin or a sulfonylurea for diabetes, as this can increase the risk of low blood sugar. You may need to monitor your blood glucose as instructed by our clinician, and your diabetes medicine dose may need to be adjusted.
  • Have severe problems with digestion or severe gastroparesis
  • Have kidney problems, as vomiting or diarrhoea may lead to dehydration
  • Take medicines for high blood pressure, as low blood pressure can occur
  • Have gallbladder problems
  • Have diabetic retinopathy, macular oedema or other problems with your eyes or vision
  • Are due to have surgery requiring anaesthesia
  • Have or have previously had severe heart failure

Do not use Foundayo during pregnancy or breastfeeding. If you are planning a pregnancy, speak to our clinician about changing your treatment, as Foundayo tablets should be stopped at least three weeks beforehand.


Foundayo and other medications

Tell our clinician about any medicines you are taking, have recently taken or may take while using Foundayo. Some medicines can change the amount of orforglipron in your blood, while Foundayo can also affect how certain other medicines work.

Medicines that may increase the concentration of Foundayo in your blood include:

  • Clarithromycin, used to treat bacterial infections
  • Itraconazole or ketoconazole, used to treat fungal infections
  • Ritonavir or telaprevir, used to treat viral infections

Medicines that may reduce the amount of Foundayo in your blood include:

  • Carbamazepine or phenytoin, used to treat seizures
  • Bosentan, used to treat pulmonary hypertension
  • Efavirenz, used to treat viral infections
  • Rifampicin, used to treat bacterial infections
  • St John's wort, a herbal product used for depression and anxiety

Foundayo may also increase the amount of certain medicines in your blood, including simvastatin and rosuvastatin, which are used to lower cholesterol, and topotecan, which is used to treat certain cancers. The clinician can advise whether additional monitoring or changes to your treatment are required.

Orforglipron pill may reduce the effectiveness of oral hormonal contraceptives. If you use oral contraception, you should consider using an additional barrier method, such as a condom, or switching to a non-oral contraceptive method for 30 days after starting the Foundayo pill and for 30 days after each dose increase.


Foundayo alternatives

Foundayo is one of several prescription weight management treatments available in the UK. These options vary in their formulation, active ingredient, dosing schedule and mechanism of action.

Treatment details Foundayo Wegovy Wegovy Pill Mounjaro
Treatment format Tablet Injection Tablet Injection
Medicine ingredient Orforglipron Semaglutide Semaglutide Tirzepatide
Dosing schedule Once daily Once weekly Once daily Once weekly
Receptors targeted GLP-1 GLP-1 GLP-1 GIP and GLP-1
Weight loss reported in trials 12.4% after 72 weeks* 20.7% after 72 weeks* 16.6% after 64 weeks* 22.5% after 72 weeks*
Prescription Status Prescription only Prescription only Prescription only Prescription only

Please note: *The weight-loss results are taken from separate clinical trials with different participants, doses, study designs and analysis methods. They are not direct head-to-head comparisons, and individual results can vary.


Foundayo vs Wegovy pill

Foundayo and the Wegovy pill are both once-daily GLP-1 medicines authorised for weight management, but they contain different active ingredients. Foundayo contains orforglipron, a non-peptide small molecule, while the Wegovy pill contains semaglutide, a peptide-based GLP-1 receptor agonist.

The main practical difference is how they are taken. Foundayo can be taken once daily at any time, with no food or water restrictions. The Wegovy pill must be taken on an empty stomach with a small amount of water, followed by a 30-minute wait before eating, drinking or taking other oral medicines.


Foundayo vs Mounjaro

Foundayo and Mounjaro are both developed by Eli Lilly but differ in their active ingredients, formulation and mechanism of action. Foundayo tablet contains orforglipron and is taken as a once-daily tablet, while Mounjaro contains tirzepatide and is administered as a once-weekly injection.

Foundayo binds to GLP-1 receptors, whereas Mounjaro targets both GIP and GLP-1 receptors, making it a dual receptor agonist. Both treatments can help regulate appetite and increase feelings of fullness, but the most appropriate option will depend on individual treatment needs and clinical suitability.


Foundayo vs Wegovy

Foundayo and Wegovy are both GLP-1 receptor agonists used for weight management, but they contain different active ingredients and are taken differently. Foundayo tablet contains orforglipron and is taken as a once-daily tablet, while Wegovy contains semaglutide and is administered as a once-weekly injection.

Both treatments act on GLP-1 receptors involved in appetite regulation and feelings of fullness. The main practical difference is their formulation and dosing schedule, with Foundayo providing a daily oral option and Wegovy providing a weekly injectable option.


Switching to Foundayo from other weight loss treatments

If you are already using Mounjaro, Wegovy injection or Wegovy pill, you may be able to switch to Foundayo without necessarily beginning at the lowest 0.8 mg dose. The appropriate starting dose depends on your current treatment and dose.

Switching should always be assessed by a clinician. Do not use the dose information below to change treatment yourself.

Can you switch from Mounjaro to Foundayo?

Yes, switching from Mounjaro to Foundayo may be possible. Your starting Foundayo dose can depend on the Mounjaro dose you are currently taking.

Current Mounjaro dose Foundayo dose
2.5 mg weekly 0.8 mg daily
5 mg weekly 2.5 mg daily
7.5 mg weekly 2.5 mg daily
10 mg weekly 5.5 mg daily
12.5 mg weekly 9 mg daily
15 mg weekly 9 mg daily

Can you switch from Wegovy Injection to Foundayo?

Yes, moving from a weekly Wegovy injection to daily Foundayo tablets may be possible. The Foundayo dose can vary according to your current Wegovy strength.

Current Wegovy injection dose Foundayo dose
0.25 mg weekly 0.8 mg daily
0.5 mg weekly 0.8 mg daily
1 mg weekly 2.5 mg daily
1.7 mg weekly 5.5 mg daily
2.4 mg weekly 9 mg daily
7.2 mg weekly 9 mg daily

Foundayo may provide an alternative for people who prefer a daily tablet rather than a weekly injection.

Can you switch from Wegovy Pill to Foundayo?

Yes, switching from the Wegovy pill to Foundayo may be possible. Your starting Foundayo dose can depend on the Wegovy pill strength you are currently taking.

Current Wegovy pill dose Foundayo dose
1.5 mg daily 0.8 mg daily
4 mg daily 0.8 mg daily
9 mg daily 2.5 mg daily
25 mg daily 5.5 mg daily

One practical difference is that Foundayo can be taken on a full or empty stomach without specific food or water restrictions.

Please note: Switching doses vary between individuals. Do not switch treatments or change your dose unless advised by a clinician.

Switching to Foundayo: Visual guide to dose changes

Switching to Foundayo: Visual Guide to Dose Changes

Is Foundayo available to buy in the UK?

Yes, Foundayo is now available in the UK. It can be accessed privately through regulated healthcare providers, including Mayfair Weight Loss Clinic, subject to clinical assessment and prescription. NHS access is considered separately through the NICE evaluation and commissioning process.

Please note: Avoid buying Foundayo tablets from unregulated or unauthorised online sellers.

FAQs About Foundayo Pill

Yes. Foundayo can be requested online through Mayfair Weight Loss Clinic. As a prescription-only medicine, it can only be supplied after a clinical assessment and approval by an appropriate prescriber.

The online process will include:

  1. Complete an online consultation: Provide accurate information about your health, medical history and other relevant details.
  2. Select your treatment: Suitable treatment options will be shown based on the information provided during your consultation.
  3. Clinical review: One of our UK-registered clinician will assess your consultation and may contact you if further information is required.
  4. Prescription and dispensing:If treatment is approved, a prescription will be generated and the medicine will be dispensed by our UK-based, GPhC-registered pharmacy.
  5. Tracked home delivery: Your treatment will be securely packaged and sent directly to your chosen address using a tracked delivery service.
No. Foundayo is a prescription-only medicine and cannot be purchased over the counter. A healthcare professional must assess whether treatment is appropriate before it can be prescribed.
No. There is currently no generic version of Foundayo pill in the UK. Foundayo contains the active ingredient orforglipron and is manufactured by Eli Lilly. Patients should only obtain prescription medicines from appropriately regulated healthcare providers and pharmacies.
Orforglipron has a half-life of approximately 29 to 49 hours, meaning the amount of medicine in your body gradually decreases after each dose. Foundayo is taken once daily to maintain its therapeutic effect, so it is important to follow the dosing schedule recommended by our clinician.
No. Foundayo is not a tablet form of Mounjaro. It contains orforglipron and acts on GLP-1 receptors, while Mounjaro contains tirzepatide and acts on both GIP and GLP-1 receptors. Both medicines are developed by Eli Lilly, but they are separate treatments with different active ingredients.
Eli Lilly's new oral weight-management medicine is Foundayo, which contains the active ingredient orforglipron. It is a once-daily GLP-1 tablet and has now received MHRA authorisation in the UK for weight loss and weight maintenance in eligible adults.
The cost of Foundayo ranges from £119 to £129, depending on the strength prescribed. The price includes the prescription, and our clinician will recommend the most appropriate strength based on your individual needs and response to treatment.
Yes. Novo Nordisk has developed an oral form of Wegovy (semaglutide), taken as a once-daily tablet. The Wegovy pill was authorised by the MHRA in June 2026 and is now available privately in the UK for eligible adults, providing another oral GLP-1 option for weight management.
MHRA authorisation means Foundayo has been approved for use in the UK for its authorised indications. However, authorisation does not mean the medicine is immediately available through the NHS or every private healthcare provider. NHS access is considered separately through NICE’s established evaluation process.
Foundayo has been authorised by the MHRA following an assessment of its quality, safety and effectiveness. However, it may not be suitable for everyone and can cause side effects. A clinician should assess your medical history and current medicines before prescribing Foundayo. Always follow the prescribed dose and read the patient information leaflet.
No, Foundayo is not considered an addictive medicine. Orforglipron pill acts on GLP-1 receptors involved in appetite and blood glucose regulation rather than producing the rewarding effects associated with addictive substances. However, speak to our clinician before stopping treatment, as appetite may increase and blood glucose levels may change after treatment ends.
You may still experience hunger while taking Foundayo, particularly during the early stages when treatment begins at a lower dose. The medicine is designed to help regulate appetite rather than eliminate hunger completely. Following a reduced-calorie diet and staying physically active remain important for supporting weight management during treatment.
There is no specific prohibition on alcohol in the Foundayo patient information leaflet. However, alcohol adds calories, can affect blood glucose levels and may make digestive symptoms such as nausea, vomiting or diarrhoea harder to manage. Ask our clinician for advice if you are unsure whether drinking alcohol is appropriate for you.
No, Foundayo does not directly burn body fat. Orforglipron tablets act on GLP-1 receptors and help regulate appetite, which can support lower food intake. When combined with a reduced-calorie diet and increased physical activity, this can help create the energy deficit required for the body to use stored energy and support weight loss.
Keep Foundayo in its original packaging to protect it from light and out of the sight and reach of children. Do not use the tablets after the expiry date shown on the packaging. If you have Foundayo tablets that you no longer need, do not dispose of them through household waste or wastewater. Ask a pharmacist how to dispose of unused medicines safely.
Foundayo is unlikely to affect your ability to drive or use machines. However, the risk of low blood sugar may increase when it is taken with insulin or a sulfonylurea. Avoid driving or using machinery if you experience symptoms of low blood sugar, such as dizziness, weakness, confusion, sweating or a fast heartbeat.
Foundayo contains less than 23 mg of sodium per tablet, which means it is considered essentially sodium-free. This information may be particularly relevant for people who are monitoring or limiting their sodium intake. If you have specific dietary requirements or concerns about sodium, discuss them with our clinician before starting treatment.